Literature DB >> 9233622

A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.

A L Shaffer1, M S Schlissel.   

Abstract

Early B cell development depends upon the surface expression of Ig heavy chain protein (mu) in a signaling complex known as the pre-B cell receptor (pre-BCR). In addition to mu, the pre-BCR consists of the surrogate light chains VpreB and lambda5 and the transmembrane signal transduction proteins Ig-alpha and Ig-beta. Expression of this complex is associated with changes in surface marker expression, gene transcription, and Ig gene rearrangement. Mutations preventing the expression of either mu or lambda5 result in developmental arrest, but the precise roles of the various components of the pre-BCR remain unclear. Using mice transgenic for a surface-expressed, but truncated, form of mu that cannot associate with surrogate light chains, we have studied the role of surrogate light chains in B cell development. We found that expression of the truncated mu transgene resulted in changes in surface marker expression, germline kappa locus transcription, and V(D)J recombinase targeting indistinguishable from those induced by intact mu protein. These experiments lead us to conclude that surrogate light chains, while necessary for the assembly of the wild-type pre-BCR, are not directly involved in pre-BCR signaling or otherwise required for early B cell development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233622

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Development of B cells expressing surface immunoglobulin molecules that lack V(D)J-encoded determinants in the avian embryo bursa of fabricius.

Authors:  C E Sayegh; S L Demaries; S Iacampo; M J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 3.  Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling.

Authors:  E M Fuentes-Pananá; J G Monroe
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 4.  Ligand-independent signaling during early avian B cell development.

Authors:  Kelly A Pike; Michael J H Ratcliffe
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Signaling pathways activated by a protease allergen in basophils.

Authors:  Rachel K Rosenstein; Jelena S Bezbradica; Shuang Yu; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

6.  Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation.

Authors:  Xiaorong Zhou; Yougui Xiang; Xiaoling Ding; William T Garrard
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

7.  Generation of heavy-chain-only antibodies in mice.

Authors:  Rick Janssens; Sylvia Dekker; Rudi W Hendriks; George Panayotou; Alexandra van Remoortere; John Kong-a San; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

8.  Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.

Authors:  R G Caldwell; R C Brown; R Longnecker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

Review 10.  Positive and negative selection during B lymphocyte development.

Authors:  John G Monroe; Gregory Bannish; Ezequiel M Fuentes-Panana; Leslie B King; Peter C Sandel; James Chung; Richard Sater
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.